ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Plasticell, JCR Partner on Stem Cell Technology in Japan – Drug Discovery & Development

Plasticell, JCR Partner on Stem Cell Technology in JapanDrug Discovery & DevelopmentPlasticell, the biotechnology company specializing in stem cell differentiation, has announced that it has signed a collaboration agreement with JCR Pharmaceuticals Co. Ltd. of Ashiya, Hyogo Pref., Japan, to discover custom stem cell culture media … …read more   &nbs… Continue reading

2014-02-25 Michael Zand NEWS

Jason Biggs stores baby’s stem cells – Express.co.uk

Express.co.ukThey have provided a testimony for the company’s website, on which they state, “We may joke a lot in life, but all kidding aside, when we learned the facts about how stem cells from cord blood and cord tissue can be used to possibly save lives, hell … and more …read more   &nbs… Continue reading

2014-02-25 Michael Zand NEWS

More Evidence of Stem Cell Errors – Scientist (blog)

More Evidence of Stem Cell ErrorsScientist (blog)An investigation by the University of Düsseldorf in Germany has found evidence of scientific misconduct related to research conducted there on stem cells used to heal damaged cardiac tissue. The conclusion follows a 2013 indictment by researchers at … …read more   &nbs… Continue reading

2014-02-25 Michael Zand NEWS

UConn Stem Cell Lines Go Global – UConn Advance (blog)

UConn Advance (blog)The University of Connecticut recently signed an agreement with a global supplier of biological research tools to market stem cells developed here to investigators studying genetic disorders around the world. The partnership with KeraFAST will ease the … …read more   &nbs… Continue reading

2014-02-25 Michael Zand NEWS

Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718 – The Herald | HeraldOnline.com (press release)

Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718The Herald | HeraldOnline.com (press release)CAMBRIDGE, Mass. — Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it has acquired the license to VS-4718 held originally by Poniard … and more …read more   &nbs… Continue reading

2014-02-25 Michael Zand NEWS

Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718 – Benzinga

Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718BenzingaVerastem (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it has acquired the license to VS-4718 held originally by Poniard Pharmaceuticals. The previous and … and more …read more   &nbs… Continue reading

2014-02-25 Michael Zand NEWS

Kerry Simon finishes second round of stem-cell treatments, finalizes plans for … – Las Vegas Sun

Kerry Simon finishes second round of stem–cell treatments, finalizes plans for …Las Vegas Sun“Iron Chef America” winner Kerry Simon wrapped up his second round of stem–cell transplants Sunday at the Mayo Clinic in Rochester, Minn., and returns here today to put the final touches on his Fight MSA fundraiser Thursday at our downtown Keep Memory … Continue reading

2014-02-25 Michael Zand NEWS

Stem Cells Acid Bath Prompts Burning Questions – Guardian Liberty Voice

Stem Cells Acid Bath Prompts Burning QuestionsGuardian Liberty VoiceA recent study indicated that stressing body cells may turn them into the pluripotent stem cells that can morph into a variety of other types. This method of generating stem cells would be easier and less expensive than the current method of making … …read more   &nbs… Continue reading

2014-02-24 Michael Zand NEWS
  • 1
  • …
  • 3,259
  • 3,260
  • 3,261
  • 3,262
  • 3,263
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.